|
2023
|
Invention
|
Istaroxime-containing intravenous formulation for the treatment of pre-cardiogenic shock and card... |
|
|
Invention
|
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf).
Co... |
|
2022
|
Invention
|
Intravenous istaroxime for the treatment of acute heart failure.
Described herein are methods of... |
|
|
Invention
|
Intravenous istaroxime for the treatment of acute heart failure. Described herein are methods of ... |
|
2021
|
Invention
|
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf). Com... |
|
2020
|
Invention
|
Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the... |
|
|
Invention
|
Inhibitors of atypical protein kinase c and their use in treating hedgehog pathway-dependent canc... |
|
2019
|
Invention
|
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf). (12... |
|
2018
|
Invention
|
Thienopyrimidine inhibitors of atypical protein kinase c. The present application provides a comp... |
|
2016
|
G/S
|
Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases ... |
|
|
G/S
|
Pulmonary lung surfactants for human use only |
|
2015
|
Invention
|
Azaquinazoline inhibitors of atypical protein kinase c. The present application provides a compou... |
|
|
G/S
|
Pharmaceutical preparations and substances for treatment of respiratory conditions; Medical devic... |
|
2014
|
Invention
|
Ventilation circuit adaptor and proximal aerosol delivery system. An adaptor for delivering an ae... |
|
2013
|
Invention
|
Azaquinazoline inhibitors of atypical protein kinase c. The present application provides azaquina... |
|
|
Invention
|
Lyophilization of synthetic liposomal pulmonary surfactant. Lyophilized pulmonary surfactants hav... |
|
|
G/S
|
Medical device, namely, a device which uses heat to generate aerosolized pharmaceutical preparati... |
|
|
G/S
|
Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmace... |
|
2011
|
G/S
|
Medical devices, namely, a device for improving delivery of
liquid, powder or aerosolized pharma... |
|
2007
|
Invention
|
Pulmonary surfactant formulations and methods for promoting mucus clearance. Methods and composit... |
|
2006
|
Invention
|
Surfactant treatment regimen. Regimens for the therapeutic or prophylactic administration of pulm... |
|
2005
|
Invention
|
Pulmonary surfactant formulations. Synthetic pulmonary surfactant compositions comprising dipalmi... |
|
|
Invention
|
Methods to produce lung surfactant formulations via lyophilization and formulations and uses ther... |
|
2004
|
G/S
|
Pulmonary lung surfactant. |
|
2003
|
G/S
|
pharmaceutical preparations and substances for treatment of respiratory conditions |
|
1995
|
G/S
|
pulmonary lung surfactant |
